Grant: Canada Research Chairs
Simon Fraser University
$100,000.00
Cellular Stress
EF 2024-25
Résumé
Neurological disorders (e.g, Alzheimer’s, Parkinson’s and related dementias) affect over 500,000 Canadians and cost the healthcare system ~$10 billion per year, representing a significant emotional and economic drain on the entire Canadian population. These diseases are caused by abnormal and toxic protein clumping in the brains of affected individuals, leading to memory loss, confusion, and impaired motor function. How and why these aggregates form is an important question that may provide insights into prevention and treatment. Scientists are struggling to find genes or environmental factors associated with the development of these neurological disorders. Dr. Timothy Audas studies a natural, reversible counterpart to these toxic clumps, where nearly identical protein aggregates form rapidly and disassemble in response to specific environmental signals. His team is using cultured mammalian cells and model organisms (e.g. fruit flies and yeast) to understand how this basic biological pathway works. Their goal is to: (1) determine which proteins aggregate under specific conditions, (2) decipher how these natural protein clumps help cells survive harsh stress treatments, and (3) identify molecules and drugs that can control this aggregation process. By learning more about this cellular pathway Dr. Audas’ team will enhance our understanding of cell adaptability, and potentially generate pharmaceutical avenues for the development of therapeutic remedies to treat those afflicted with debilitating neurological disorders.
Programme
Canada Research Chairs
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
CRC-2021-00117
Name nom
Audas, Timothy
Department département
Molecular Biology and Biochemistry - Simon Fraser University
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
100000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1060204
Field of research list names en
Protein trafficking in cell biology
Field of research list names fr
Transport des protéines en biologie cellulaire
Socioeconomic objective list codes
RDS10799
Socioeconomic objective list names en
Health, n.e.c.
Socioeconomic objective list names fr
Santé, n.c.a.
Application title
Cellular Stress
Keywords
Cellular Stress; Amyloid; Heat Shock; noncoding RNA; Protein Aggregation; Subnuclear Structures; Thermosensors; Nuclear Translation
Application summary
Neurological disorders (e.g, Alzheimer’s, Parkinson’s and related dementias) affect over 500,000 Canadians and cost the healthcare system ~$10 billion per year, representing a significant emotional and economic drain on the entire Canadian population. These diseases are caused by abnormal and toxic protein clumping in the brains of affected individuals, leading to memory loss, confusion, and impaired motor function. How and why these aggregates form is an important question that may provide insights into prevention and treatment. Scientists are struggling to find genes or environmental factors associated with the development of these neurological disorders. Dr. Timothy Audas studies a natural, reversible counterpart to these toxic clumps, where nearly identical protein aggregates form rapidly and disassemble in response to specific environmental signals. His team is using cultured mammalian cells and model organisms (e.g. fruit flies and yeast) to understand how this basic biological pathway works. Their goal is to: (1) determine which proteins aggregate under specific conditions, (2) decipher how these natural protein clumps help cells survive harsh stress treatments, and (3) identify molecules and drugs that can control this aggregation process. By learning more about this cellular pathway Dr. Audas’ team will enhance our understanding of cell adaptability, and potentially generate pharmaceutical avenues for the development of therapeutic remedies to treat those afflicted with debilitating neurological disorders.